Phase 2 Readout~quarter

Phase 2 Readout: opgx-lca5

Indication
LCA5

Other upcoming events for IRD

Phase 2 StartPhase 2 Start: A Phase 1b/2a Open-Label, Dose-Exploration Study to Investigate the Safety and Tolerability of Subre
Phase 2 ReadoutPhase 2 Readout: pipeline candidate

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 2 Readout: opgx-lca5 — IRD Phase 2 Readout | BioSniper